2. Metabolic Enzyme/Protease
  3. PI4P5K
  4. ISA-2011B

ISA-2011B is a PIP5K1α inhibitor with promising anticancer effects .

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 1395347-24-6

容量 価格（税別） 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 319 在庫あり
Solution
10 mM * 1 mL in DMSO USD 319 在庫あり
Solid
1 mg $132 在庫あり
5 mg $290 在庫あり
10 mg $460 在庫あり
25 mg $900 在庫あり
50 mg $1350 在庫あり
100 mg $1820 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 19 publication(s) in Google Scholar

ISA-2011B 関連抗体

Top Publications Citing Use of Products

    ISA-2011B purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Oct 15;16(1):9160.  [Abstract]

    Confocal laser scanning microscopy (CLSM) imaging of apoptotic MEFs treated with a BH3-mimetic cocktail (5 μM ABТ-737, 10 µM S63845) with and without migrasome inhibitors SMS2-IN-1 (30 uM) and, ISA-2011B (20 µM). MEFs were stained with SiR-actin, A5-FITC, and Hoechst 33342, to visualise F-actin, the nucleus, and exposed phosphatidylserine, respectively.

    ISA-2011B purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 May 23:e04372.  [Abstract]

    HCC cells (PLC, Hep3B, 97L, 97H, LM3, and SK‐HEP‐1) were treated with increasing doses of ISA-2011B (6.25, 12.5, 25, 50, and 100 µM) for 24 h, and the cell viability was measured by CCK8 assay (n = 3). IC50 values of each cell line are summarized in the top‐right corner.

    ISA-2011B purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 May 23:e04372.  [Abstract]

    Representative image of subcutaneous xenografts models inoculated with SK-Hep-1 cells. Seven days post-inoculation, mice received either control or ISA-2011B (40 mg/kg) through injection intraperitoneally once every other day for 14 days (n=6).

    ISA-2011B purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 May 23:e04372.  [Abstract]

    Representative H&E staining of heart, kidney and lung tissues form all treatment groups. The results showed that no obvious toxicity was observed in the major organs (liver, lung or kidney) of mice treated with ISA-2011B (40 mg/kg; i.p.; once every other day for 14 days). Scale bar: 200 μm.

    ISA-2011B purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 May 23:e04372.  [Abstract]

    Serum levels of ALT were detected in all treatment groups. The results showed that serum liver function indicators remained unchanged in mice treated with ISA-2011B (40 mg/kg;i.p.; once every other day for 14 days).

    ISA-2011B purchased from MedChemExpress. Usage Cited in: J Cell Mol Med. 2018 Sep;22(9):4117-4129.  [Abstract]

    Effect of ISA-2011B or its gene knockout on cancer cell proliferation. Colony formation assays are performed in SKBR3 cells treated with ISA-2011B (20 μM) or DMSO as a control.

    • 生物活性

    • プロトコル

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    ISA-2011B is a PIP5K1α inhibitor with promising anticancer effects .

    体外実験

    The proliferation rate of PC-3 cells after treatment with ISA-2011B at 10, 20, and 50 μM is significantly reduced to 58.77%, 48.65%, and 21.62% of vehicle-treated controls, respectively. ISA-2011B exhibits the highest binding affinity to PIP5K1α, and to MAP/microtubule affinity-regulating kinase 1 and 4 (MARK1 and MARK4) across 460 kinases. ISA-2011B treatment inhibits PIP5K1α expression by 78.6% in PC-3 cells[1]. ISA-2011B leads to a remarkable reduction in AR-V7 and CDK1 in both nucleus and cytoplasm of 22Rv1 cells. ISA-2011B treatment also abolishes AR expression in the nucleus, without depleting the cytoplasmic AR[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    ISA-2011B 関連抗体
    体内実験

    ISA-2011B significantly inhibits growth of tumor cells in xenograft mice, and is mediated by targeting PIP5K1α-associated PI3K/AKT and the downstream survival, proliferation, and invasion pathways[1]. Overexpression of AR-V7 increases PIP5K1α, promotes rapid growth of PCa in xenograft mice, whereas inhibition of PIP5K1α by its inhibitor ISA-2011B suppresses the growth and invasiveness of xenograft tumors overexpressing AR-V7. ISA-2011B disrupts protein stabilization of AR-V7 which is dependent on PIP5K1α, leading to suppression of invasive growth of AR-V7-high tumors in xenograft mice[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
    分子量

    423.85

    分子式

    C22H18ClN3O4
    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C(N1[C@H](C2=CNC3=C2C=C(Cl)C=C3)C4=C(C=C5C(OCO5)=C4)C[C@]16[H])CN(C)C6=O
    輸送条件

    Room temperature in continental US; may vary elsewhere.
    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 100 mg/mL (235.93 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.3593 mL 11.7966 mL 23.5933 mL
    5 mM 0.4719 mL 2.3593 mL 4.7187 mL
    10 mM 0.2359 mL 1.1797 mL 2.3593 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始）

    C1

    ×
    体積 （開始）

    V1

    =
    濃度 （終了）

    C2

    ×
    体積 （終了）

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (5.90 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (5.90 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 4 mg/mL (9.44 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    % 
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 99.85% ee.: 100.00%

    COA (261 KB) HNMR (183 KB) RP-HPLC (206 KB) LCMS (290 KB)

    取扱説明書 (2659 KB)
    参考文献
    細胞実験
    [2]

    Cells are grown in phenol red-free RPMI-1640 medium 24 hours and then are treated with drugs alone or in combination for 24 hours or 48 hours. MDV3100 at 5 μM or ISA-2011B at 20 μM or 50 μM final concentrations or solvent DMSO 1% is used. For treatment of 22Rv1 cells with MG132, a proteasome inhibitor, cells are treated with MG132 at 1 μM. For combination treatment of MG132 and ISA-2011B, cells are pre-treated with MG132 for 30 min at 1 μM prior to treatment of ISA-2011B[2].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。
    動物実験
    [1]

    Mice: BALB/c nude mice aged 8 to 12 wk are used in the experiments. Tumor cells are implanted into the mice. Tumor xenografts are treated with vehicle (control), RP-56976 (10 mg/kg), ISA-2011B (40 mg/kg), and RP-56976 (10 mg/kg) in combination with ISA-2011B (40 mg/kg) every second day[1].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。
    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.3593 mL 11.7966 mL 23.5933 mL 58.9831 mL
    5 mM 0.4719 mL 2.3593 mL 4.7187 mL 11.7966 mL
    10 mM 0.2359 mL 1.1797 mL 2.3593 mL 5.8983 mL
    15 mM 0.1573 mL 0.7864 mL 1.5729 mL 3.9322 mL
    20 mM 0.1180 mL 0.5898 mL 1.1797 mL 2.9492 mL
    25 mM 0.0944 mL 0.4719 mL 0.9437 mL 2.3593 mL
    30 mM 0.0786 mL 0.3932 mL 0.7864 mL 1.9661 mL
    40 mM 0.0590 mL 0.2949 mL 0.5898 mL 1.4746 mL
    50 mM 0.0472 mL 0.2359 mL 0.4719 mL 1.1797 mL
    60 mM 0.0393 mL 0.1966 mL 0.3932 mL 0.9831 mL
    80 mM 0.0295 mL 0.1475 mL 0.2949 mL 0.7373 mL
    100 mM 0.0236 mL 0.1180 mL 0.2359 mL 0.5898 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    ISA-2011B Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    ISA-2011B1395347-24-6PI4P5KPhosphatidylinositol 4-phosphate 5-kinasesInhibitorinhibitorinhibit

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

    		  

    カスタマ需要量 *

    お名前 *

    		 

    タイトル

    メールアドレス *

    		 

    電話番号 *

    デパートメント

    		 

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

    		      

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    ISA-2011B
    製品番号:
    HY-16937
    数量:
    MCE 日本正規代理店:

    カスタマーレビュー

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    製品名

    		  

    Lot #

    お名前 *

    		 

    メールアドレス *

    電話番号 *

    		 

    部門 *

    組纖名 *

    		 

    国或いは地域 *

    備考

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.